Skip to main content

Table 3 In-hospital outcomes between SLE and matched-control patients*

From: The impact of systemic lupus erythematosus on the risk of infection after total hip arthroplasty: a nationwide population-based matched cohort study

 

SLE

Control

P

(n = 325)

(n = 325)

Pneumonia

0 (0.0%)

0 (0.0%)

1.00

Urinary tract infection

6 (2.5%)

7 (2.6%)

0.94

Pulmonary embolism

0 (0.0%)

0 (0.0%)

1.00

Sepsis

0 (0.0%)

0 (0.0%)

1.00

Deep vein thrombosis

1 (0.3%)

0 (0.0%)

0.31

In-hospital mortality

0 (0.0%)

0 (0.0%)

1.00

  1. SLE systemic lupus erythematosus
  2. *Data are presented as number and percentage